National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

paclitaxel albumin-stabilized nanoparticle formulation (PAK-lih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kil for-myoo-LAY-shun)

 A drug used to treat breast cancer that has spread or that has come back within 6 months after chemotherapy. It is also being studied in the treatment of newly diagnosed breast cancer and other types of cancer. Paclitaxel albumin-stabilized nanoparticle formulation is a type of mitotic inhibitor. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and protein-bound paclitaxel.



Previous Definitions:PABA, pacemaker, Pacific valerian, pack year, paclitaxel
Next Definitions:paclitaxel liposome, paclitaxel poliglumex, paclitaxel polyglutamate, Paget disease of bone, Paget disease of the nipple

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov